Product Description

Insulin lispro is used to treat people with type 1 or type 2 diabetes.[3] People who have good results with rapid-acting insulin should not routinely switch to insulin lispro, but may benefit from some benefits such as flexibility and responsiveness. Using recombinant DNA technology, the final lysine and proline residues found at the C-terminus of the B chain are reversed. This modification does not alter receptor binding, but blocks the formation of insulin dimers and hexamers. This allows larger quantities of active monomeric insulin to be immediately available for postprandial injections.